United Kingdom


GreenLight for medical cannabis in Europe

Discover how GreenLight Pharmaceuticals Ltd is aiming to advance clinical research, access and education regarding medical cannabis in Europe.

Established in 2014, GreenLight Pharmaceuticals Ltd is an Irish biopharmaceutical company focused on developing safe and effective plant-based medicines. GreenLight specialises in phytocannabinoid research and clinical development. The company is based in Dublin but has recently created a UK based subsidiary and has plans to expand its world of medical cannabis in Europe.


Is CBD oil the world's most addictive beauty drug?

How does one respond when your hairdresser gives you a syringe alongside your herbal tea? I hold it up to the light. 'You just pop it under your tongue, wait a few seconds, then swallow,’ the young woman explains, gesturing to the amber liquid within it. I obey. The herbal droplets fall into my mouth. They feel thick and slippery, like vegetable oil. And then I wait… and wait for a beauty miracle to happen.


Tilray speeds expansion in Europe

Tilray Inc. is expanding its European leadership team and setting up a hub in Portugal, deepening its planned international reach.

The company appointed five senior members to its European team, according to a statement Friday. Arne Wilkens, a former executive at the German pharmaceuticals company AiCuris, will take on the role of vice president of business expansion in Europe.


UK hemp industry: can this help emissions targets and revitalise the agriculture industry?

The UK hemp industry is on the rise, and leaders of the sector are exploring the potential of hemp and its benefits for agriculture, carbon reduction and other environmental industries.

Leaders of the UK hemp industry will convene for The Hemp Party at Greenhaus on 12 July to discuss the potential of hemp and its benefits for agriculture, carbon reduction and other environmental and economic industries in the UK and around the world.


‘Five years’ to decriminalization of cannabis in U.K., say Politicians

CANNABIS supporting British politicians believe that within five years it could be decriminalized in the U.K.

Speaking at Cannabis Europa, Labour Party Member of Parliament (MP) Norman Lamb said the last time the House of Commons voted on the issue – in December last year – there were 52 votes in favor. He said: “It could happen, and it could happen really quickly. I don’t believe it will take much for the main Parties to shift their position.


Cannabidiol quality in the UK found lacking

The UK’s Centre for Medicinal Cannabis (CMC) has revealed some disturbing results in its report on cannabidiol products sold in the nation.

Cannabidiol (CBD) use is growing in the UK. According to the CMC report, between 8- 11% of UK adults have tried CBD. The CMC says the UK CBD market is larger than the nation’s total Vitamin D and Vitamin C market combined, and states the current ‘hype’ around cannabidiol is not a passing fad – it is likely to endure.


The cannabis system in the UK deserves a total rehaul

The UK is one of the biggest producers of cannabis, yet cannabis laws in this country haven’t essentially changed since the early ’70s when it was declared a Class B drug.

UK and cannabis have had a very intertwined history, from the days of the great East India Company to today’s smugglers who bring the goods from Spain, Netherlands, and Morocco all the way up to the British Isles.

Cannabis has been bought, traded and sold throughout British history simply due to the fact that the UK was present all over the globe at one point.

In the 19th century, cannabis was used as a drug after a physician who studied the plant brought a large quantity of cannabis with him on his return to Britain in 1842.


63 per cent of Londoners think UK should follow Canada and make drug legal

Londoners overwhelmingly support the legalisation of cannabis for adult recreational use, according to a poll commissioned by the Evening Standard and the independent think-tank Volteface. 

Sixty-three per cent of residents in the capital back legalisation and regulation of the class B drug, with just 19 per cent opposing the idea. In the country at large, 47 per cent back legalisation, with 30 per cent against and 23 per cent undecided. 

The poll, carried out by  Survation at the start of a major Standard investigation into cannabis reform, is the first test of public opinion since medical cannabis was legalised in the UK last November.


CBD regulations in spotlight as Cannabis Europa opens in London

One of Europe’s leading CBD industry figures says it needs to clean-up its image and get rid of the ‘charlatans and cowboys’.

Speaking at Cannabis Europa Mark Reinders, chairman of the of the European Industrial Hemp Association (EIHA), says it is still looking at ways to resolve the on-going dispute with the European Union over the classification of CBD as a Novel Food.

He said: “Dealing with the EU on the Novel Food issue is like playing a game of football (soccer) for 90 minutes and seeing the rules changed six times.”


Through the smoke: The legal path to Britain’s cannabis market

The great and the good of the global cannabis industry (which, for those behind the curve on such things, is no longer a contradiction in terms), are assembling in London for a dazzling set of events under the banner of European Cannabis Week. 

Even those who follow the headlines about the industry’s rapidly escalating size and changing regulatory landscape may be surprised both by the sheer scale of the exercise and by the profiles of those attending, many of whom have high-powered, successful backgrounds in more conventional sectors.

This, lest there still be any doubt from anyone, is proper, serious business. 


Subscribe to RSS - United Kingdom